This Article Full Text Full Text (PDF) All Versions of this Article: 37/9/2420    most recent 01.STR.0000236632.58323.cdv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yokoyama, H. Articles by Yamasaki, Y. Search for Related Content PubMed PubMed Citation Articles by Yokoyama, H. Articles by Yamasaki, Y. Related Collections Pathophysiology Type 2 diabetes

(Stroke. 2006;37:2420.)
© 2006 American Heart Association, Inc.

Progress Reviews

Recent Advances of Intervention to Inhibit Progression of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes Mellitus

From the Department of Internal Medicine, Jiyugaoka Medical Clinic, Obihiro (H.Y.), and Department of Internal Medicine and Therapeutics, Osaka University, Osaka (N.K., Y.Y.), Japan.

Correspondence and reprint requests to Hiroki Yokoyama, MD, PhD, Department of Internal Medicine, Jiyugaoka Medical Clinic, Jiyugaoka 1-1-10, Obihiro 080-0848, Japan. E-mail hiroki{at}m2.octv.ne.jp

Background and Purpose— Type 2 diabetes is associated with a high cardiovascular morbidity and mortality. Recent advances of intervention studies in type 2 diabetes with use of carotid intima-media thickness (CIMT) measurement as a surrogate end point may allow for better understanding of the undetermined process of atherosclerosis, the effect of interventions, and the usefulness of CIMT to inhibit events of cardiovascular disease.

Summary of Review— Data were available from 11 studies (n=1578) in subjects with type 2 diabetes (including impaired glucose tolerance, n=132) that evaluated the effect of interventions on change in CIMT. The overall weighed rate of change in mean CIMT based on data among control groups (ie, type 2 diabetes without interventions) was 0.034 mm/y (95% CI, 0.029 to 0.039; median SD, 0.054), in which mean HbA_1c was 7.86% (95% CI, 7.72 to 8.00; median SD, 1.5). A significant close correlation of HbA_1c with rate of CIMT change was found (R²=0.35, P=0.01). Agents for lowering of blood glucose, platelet activation, or blood pressure significantly reduced the CIMT increase, independent of blood glucose control. This implies that other mechanisms of such agents to diminish CIMT increase should be explored.

Conclusions— CIMT measurement may contribute to elucidating the short- and/or long-term effect of interventions on the rate of change in CIMT in relation to the levels of various risk factors. Although the method needs further standardization, pharmacological interventions are likely to inhibit progression of CIMT, leading to a reduction of cardiovascular events.

Key Words: atherosclerosis • carotid arteries • diabetes mellitus • glucose • intervention studies • intima-media thickness

This article has been cited by other articles:

				D. Sander, K. Sander, and H. Poppert Review: Stroke in type 2 diabetes The British Journal of Diabetes & Vascular Disease, September 1, 2008; 8(5): 222 - 229. [Abstract] [PDF]

				H. Yokoyama, K. Kawai, M. Kobayashi, and on behalf of the Japan Diabetes Clinical Data Mana Microalbuminuria Is Common in Japanese Type 2 Diabetic Patients: A nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10) Diabetes Care, April 1, 2007; 30(4): 989 - 992. [Full Text] [PDF]

				T. Mazzone, P. M. Meyer, S. B. Feinstein, M. H. Davidson, G. T. Kondos, R. B. D'Agostino Sr, A. Perez, J.-C. Provost, and S. M. Haffner Effect of Pioglitazone Compared With Glimepiride on Carotid Intima-Media Thickness in Type 2 Diabetes: A Randomized Trial JAMA, December 6, 2006; 296(21): 2572 - 2581. [Abstract] [Full Text] [PDF]